Proteomics
Federal R&D funding for universities tops 3% in fiscal year 2021
Federally funded R&D for U.S. higher education universities grew 3.3% to $86.4 billion in fiscal year 2021 (end-September 30, 2021), according to the latest statistics from the National Science Foundation. Funding from the federal government accounted for 53% of the total and increased 3.7%. Read More
Applied DNA and EvviVax publish data for potential cancer immunotherapy
Applied DNA Sciences and EvviVax have published a manuscript detailing a preclinical study showing that LinearDNA vaccines used for cancer immunotherapy produced a strong immune and specific antitumoral response in preclinical mouse models. The study investigated the use of the LinearDNA platform to produce DNA vaccines targeting either tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs, or tumor neoantigens). Read More
Machine vision advances single-cell sequencing for small samples
The ability to sequence RNA in single cells has given scientists an unprecedented level of resolution in studying rare cell types. However, current approaches are designed to deal with a large number of cells, making it difficult to work with small samples. New research, published in Nature Methods on February 14, has described a technique using machine vision to detect cells and make single-cell RNA sequencing more efficient at a smaller scale. Read More
PerkinElmer highlights new workflows at SLAS 2022
BOSTON - Following a series of acquisitions of Horizon Discovery, BioLegend, Nexcelom Bioscience, and Omni International in 2021, PerkinElmer showcased end-to-end life sciences workflows at the Society for Laboratory Automation and Screening (SLAS) 2022 International Conference and Expo. Read More
Colonic gene mapping provides insights into intestinal diseases
Researchers have used spatial transcriptomics to uncover an unprecedented view of the molecular regionalization of the murine colon. This research, published in Nature Communications on February 11, provides novel insights into inflammatory bowel disease. Read More
Bio-Rad develops antidaratumumab antibodies for drug monitoring
Bio-Rad Laboratories has launched a range of antidaratumumab antibodies that are specific for daratumumab (Darzalex) and inhibit the binding of the drug to its target, CD38. These highly specific and high-affinity recombinant antibodies are suitable for bioanalysis and drug monitoring of daratumumab and its biosimilars, according to the company. Read More
mRNA-based therapeutics pioneer innovation in the biopharmaceutical industry
In the age of COVID-19, many novel therapeutics have been brought to the forefront, most notably mRNA-based therapies. This technology has been used in two of the most prominent COVID-19 vaccines currently available in the U.S. under the U.S. Food and Drug Administration emergency use authorization. As a result, some companies are expanding mRNA-based technology to apply it to other therapies while further strengthening its use in vaccines. Read More
IsoPlexis uses proteomics to identify early factors of long COVID
IsoPlexis has published a study in Cell, led by the Institute for Systems Biology and the Seattle COVID Consortium, in which researchers used IsoPlexis' single-cell functional proteomics platform to identify factors that may predict sustained disease after COVID-19 infection, also known as post-acute sequelae of COVID-19 (PASC) or long COVID. Read More
What will digital transformation in research labs look like?
BOSTON - Data communication and management are crucial for digital transformation and the acceleration of important scientific discoveries, according to Sridhar Iyengar, CEO of Elemental Machines. Iyengar gave a presentation titled "Why Data Maturity Is Essential to the Lab of the Future" at the Society for Laboratory Automation and Screening 2022 International Conference and Expo on February 7. Read More
How to future ready businesses with diversity, equity, inclusion
BOSTON - What practices should organizations in the life sciences deploy to attract, develop, and retain the future workforce? Keynote speaker at the Society for Laboratory Automation and Screening 2022 conference, Raven Solomon, a diversity, equity, and inclusion (DEI) thought leader, provided a business case why DEI should be a priority for businesses. Read More
Conferences
Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Conferences
Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter